Enforced expression of Runx2 perturbs T cell development at a stage coincident with β-selection

Journal of Immunology

Volumn 169, Issue 6, 2002, Pages 2866-2874

  Vaillant, François ^a   Blyth, Karen ^a   Andrew, Linda ^a   Neil, James C ^a   Cameron, Ewan R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GENE PRODUCT; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOMA; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE;

EID: 0037105587     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.6.2866     Document Type: Article

References (60)

1. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
2. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α
3. AML1, AML2, and AML3, the human members of the runt domain genefamily: cDNA structure, expression, and chromosomal localization
4. Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain
5. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1
6. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor
7. Expression of the Runt domain-encoding PEBP2α genes in T cells during thymic development
8. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis
9. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
10. Core-binding factor: A central player in hematopoiesis and leukemia
11. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
12. Regulation of chondrocyte differentiation by Cbfa1
13. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
14. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia
15. Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia
16. Multicolor spectral karyotyping identifies novel translocations in childhood acute lymphoblastic leukemia
17. Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21
18. AML1 gene amplification: A novel finding in childhood acute lymphoblastic leukemia
19. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc
20. Cbfa1/Runx2: A novel oncogenic pathway revealed by in vivo complementation and retroviral tagging
21. Signal transduction pathways regulating the development of αβ T cells
22. αβ/γδ lineage commitment in the thymus of normal and genetically manipulated mice
23. Transcriptional regulation of T lymphocyte development and function
24. Branching out to gain control: How the pre-TCR is linked to multiple functions
25. Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): Evidence for a new myc collaborating oncogene
26. Lymphoid development in mice congenitally lacking T-cell receptor α/β-expressing cells
27. + cytolytic T cells
28. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
29. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
30. Moloney murine leukaemia virus-induced lymphomas in p53 deficient mice: Overlapping pathways in tumour development
31. A PCR strategy to distinguish heterozygous and homozygous gene. "Knockout" transgenic mice
32. + cells
33. The regulation of CD4 and CD8 coreceptor gene expression during T cell development
34. Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor β
35. Runx2: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging
36. Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis
37. Regulation of immune responses by TGF-β
38. Immunomodulatory effects of transforming growth factor-β on T lymphocytes: Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes
39. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad 5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2Cl2
40. A RUNX2/PEBP2αA/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia
41. Smad-Runx interactions during chondrocyte maturation
42. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells
43. Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35pter
44. Overexpression of AML1 transcription factor drives thymocytes into the CD8 single-positive lineage
45. Cbfa1, an essential transcription factor for bone formation, is expressed in testis from the same promoter used in bone
46. Premature TCR αβ expression and signaling in early thymocytes impair thymocyte expansion and partially block their development
47. Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo
48. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during αβ thymopoiesis
49. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas
50. An HMG-box-containing T-cell factor required for thymocyte differentiation
51. Redundant regulation of T cell differentiation and TCRα gene expression by the transcription factors LEF-1 and TCF-1
52. SCL and LMO1 alter thymocyte differentiation: Inhibition of E2A-HEB function and pre-T α chain expression
53. + distinguished in the early growth response (Egr)-1 transgenic mice with a recombinase-activating gene-deficient background
54. Delayed thymocyte development induced by augmented expression of p561ck
55. + precursors
56. Regulation of early T cell development by the engagement of TCR-β complex expressed on fetal thymocytes from TCR-β-transgenic scid mice
57. Proliferation kinetics associated with T cell receptor-β chain selection of fetal murine thymocytes
58. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: Parallels with E2A-deficient mice
59. scid thymocytes with TCRβ gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes
60. Constitutive activation of NF-κB and T-cell leukemia/lymphoma in Notch3 transgenic mice